Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07028216 · ClinicalTrials.gov registry record · NA

Mindful Self-compassion for Anxiety and Depression: Impact of Delivery Method

A NA study of Major Depressive Disorder and Anxiety Disorders, sponsored by Georgetown University.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT07028216: Recruiting NA study of Major Depressive Disorder and Anxiety Disorders, sponsored by Georgetown University.

NCT07028216 is a NA study of Major Depressive Disorder and Anxiety Disorders that is actively recruiting participants, run by Georgetown University. The registered enrollment target is 80 participants, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07028216, a NA study of Major Depressive Disorder and Anxiety Disorders, is actively recruiting participants, sponsored by Georgetown University.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The study will compare the delivery of an 8-week Mindful Self-Compassion training, in-person against video-conference, on anxiety and depression symptom severity in patients with diagnosed anxiety disorders (generalized anxiety disorder, social anxiety disorder, and panic disorder) or major depressive disorder or dysthymia.

Primary Outcome

10-item questionnaire that measures ruminative processes related to self-critical thoughts.

Interventions

  • BEHAVIORAL Mindful Self-Compassion

Study Locations (1)

District of Columbia

  • Georgetown University Medical Center - Washington D.C.

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2025-06
Est. Completion 2026-08-31
Phase NA
Georgetown University

227 total trials

What NCT07028216 shows while recruiting

NCT07028216 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (79% lower).

The record links to 7 conditions, with Major Depressive Disorder appearing as the primary indexed condition, and to 1 intervention - of which Mindful Self-Compassion is the first listed.

NCT07028216 reports a single indexed study location in District of Columbia.

Frequently Asked Questions

What is clinical trial NCT07028216 about?

NCT07028216 is a clinical study titled "Mindful Self-compassion for Anxiety and Depression: Impact of Delivery Method". The study will compare the delivery of an 8-week Mindful Self-Compassion training, in-person against video-conference, on anxiety and depression symptom severity in patients with diagnosed anxiety disorders (generalized anxiety disorder, social anxiety disorder, and panic disorder) or major depressi...

What is the current status of trial NCT07028216?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2025-06. Estimated completion is 2026-08-31.

What conditions does trial NCT07028216 study?

This clinical trial studies the following conditions: Major Depressive Disorder, Anxiety Disorders, Generalized Anxiety Disorder, Social Anxiety Disorder, Panic Disorder.

What interventions are being tested in trial NCT07028216?

The interventions under investigation include: Mindful Self-Compassion (BEHAVIORAL).

Who is sponsoring clinical trial NCT07028216?

This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07028216 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Major Depressive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07028216's enrollment target sits among peer trials

80 143rd of 282 higher than 134 of 282 other Major Depressive Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Major Depressive Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT07028216, the US trial registry maintained by the National Library of Medicine. NCT07028216 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.